Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial
In: Beneficial MicrobesSearch for other papers by R. Russo in
Current site
Google Scholar
Search for other papers by E. Karadja in
Current site
Google Scholar
Search for other papers by F. De Seta in
Current site
Google Scholar
Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women. It is characterised by abnormal vaginal microbiota with a depletion of lactobacilli and predominance of anaerobic microorganisms, mainly Gardnerella vaginalis and Atopobium vaginae. Although antibiotics represent an effective therapeutic option in the short-term, recurrent infections still remain a serious problem. Nowadays, evidence exists about the efficacy of probiotics for the management of BV. The aim of the current double blind, randomised clinical trial was to assess the efficacy of a probiotic mixture, including Lactobacillus acidophilus GLA-14 and Lactobacillus rhamnosus HN001, in combination with bovine lactoferrin, as adjuvant therapy to metronidazole in women with recurrent BV. In particular, normalisation of Nugent score, remission of symptoms and recurrences during a six-months follow-up were assessed. 48 adult women received metronidazole (500 mg twice daily) for 7 days and randomly assigned to take simultaneously either probiotics plus lactoferrin or placebo (2 capsules/day for 5 days followed by 1 capsule/day for 10 consecutive days; induction phase). The verum or placebo administration (1 capsule/day for 10 consecutive days) was repeated each month (maintenance phase) during the six months of follow-up starting the first day of menstrual cycle since the menstrual blood increases the vaginal pH and contributes to increase the risk of recurrences. The results showed that symptoms (vaginal discharge and itching), Nugent score and recurrence rate were significantly improved by probiotics mixture in association with lactoferrin. This alternative approach may represent a safe and effective remedy for the restoration of healthy vaginal microbiota in preventing recurrent BV.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Abdali, K., Jahed, L., Amooee, S., Zarshenas, M., Tabatabaee, H. and Bekhradi, R., 2015. Comparison of the effect of vaginal zataria multiflora cream and oral metronidazole pill on results of treatments for vaginal infections including trichomoniasis and bacterial vaginosis in women of reproductive age. Biomed Research International 2015: 683640.
'Comparison of the effect of vaginal zataria multiflora cream and oral metronidazole pill on results of treatments for vaginal infections including trichomoniasis and bacterial vaginosis in women of reproductive age ' () 2015 Biomed Research International : 683640.
-
Amaya-Guio, J., Viveros-Carreño, D.A., Sierra-Barrios, E.M., Martinez-Velasquez, M.Y. and Grillo-Ardila, C.F., 2016. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database of Systematic Review 10: CD011701.
'Antibiotic treatment for the sexual partners of women with bacterial vaginosis ' () 10 Cochrane Database of Systematic Review : CD011701.
-
Anukam, K., Osazuwa, E., Ahonkhai, I., Ngwu, M., Osemene, G., Bruce, A.W. and Reid, G., 2006. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes and Infections 8: 1450-1454.
'Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial ' () 8 Microbes and Infections : 1450 -1454.
-
Bertuccini, L., Russo, R., Iosi, F. and Superti, F., 2017. Effects of Lactobacillus rhamnosus and Lactobacillus acidophilus on bacterial vaginal pathogens. International Journal of Immunopathology and Pharmacology 30: 163-167.
'Effects of Lactobacillus rhamnosus and Lactobacillus acidophilus on bacterial vaginal pathogens ' () 30 International Journal of Immunopathology and Pharmacology : 163 -167.
-
Bertuccini, L., Russo, R., Iosi, F. and Superti, F., 2018. Lactobacilli and lactoferrin: biotherapeutic effects for vaginal health. Journal of Functional Foods 45: 86-94.
'Lactobacilli and lactoferrin: biotherapeutic effects for vaginal health ' () 45 Journal of Functional Foods : 86 -94.
-
Bohbot, J.M., Daraï, E., Bretelle, F., Brami, G., Daniel, C. and Cardot, J.M., 2018. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. Journal of Gynecology Obstetrics and Human Reproduction 47: 81-86.
'Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence ' () 47 Journal of Gynecology Obstetrics and Human Reproduction : 81 -86.
-
Centers for Disease Control and Prevention (CDC), 2015. Sexually transmitted diseases: summary of 2015 CDC treatment guidelines. Journal of the Mississippi State Medical Association 56: 372-375.
-
Chavoustie, S.E., Jacobs, M., Reisman, H.A., Waldbaum, A.S., Levy, S.F., Hillier, S.L. and Nyirjesy, P., 2015. Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study. Journal of Low Genital Tract Disease 19: 129-134.
'Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study ' () 19 Journal of Low Genital Tract Disease : 129 -134.
-
Cianci, A., Giordano, R., Delia, A., Grasso, E., Amodeo, A., De Leo, V. and Caccamo, F., 2008. Efficacy of Lactobacillus rhamnosus GR-1 and of Lactobacillus reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecologica 60: 369-376.
'Efficacy of Lactobacillus rhamnosus GR-1 and of Lactobacillus reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses ' () 60 Minerva Ginecologica : 369 -376.
-
Cristiano, L., Rampello, S., Noris, C. and Valota, V., 1996. Bacterial vaginosis: prevalence in an Italian population of asymptomatic pregnant women and diagnostic aspects. European Journal of Epidemiology 12: 383-390.
'Bacterial vaginosis: prevalence in an Italian population of asymptomatic pregnant women and diagnostic aspects ' () 12 European Journal of Epidemiology : 383 -390.
-
De Alberti, D., Russo, R., Terruzzi, F., Nobile, V. and Ouwehand, A.C., 2015. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study. Archives of Gynecology and Obstetrics 292: 861-867.
'Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study ' () 292 Archives of Gynecology and Obstetrics : 861 -867.
-
Falagas, M., Betsi, G. and Athanasiou, S., 2007. Probiotics for the treatment of women with bacterial vaginosis. Clinical Microbiology and Infections 13: 657-664.
'Probiotics for the treatment of women with bacterial vaginosis ' () 13 Clinical Microbiology and Infections : 657 -664.
-
Grin, P.M., Kowalewska, P.M., Alhazzan, W. and Fox-Robichaud, A.E., 2013. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Canadian Journal of Urology 20: 6607-6614.
'Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis ' () 20 Canadian Journal of Urology : 6607 -6614.
-
Jang, S.E., Jeong, J.J., Choi, S.Y., Kim, H., Han, M.J. and Kim, D.H., 2017. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus GLA-14 attenuate Gardnerella vaginalis-infected bacterial vaginosis in mice. Nutrients 9: 23.
'Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus GLA-14 attenuate Gardnerella vaginalis-infected bacterial vaginosis in mice ' () 9 Nutrients : 23.
-
Kasaro, M.P., Husnik, M.J., Chi, B.H., Reid, C., Magure, T., Makanani, B., Tembo, T., Ramjee, G., Maslankowski, L., Rabe, L., Brad Guffey, M., 2017. Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study. International Journal of STD and AIDS 28: 467-475.
'Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study ' () 28 International Journal of STD and AIDS : 467 -475.
-
Larsson, P.G., Stray-Pedersen, B., Ryttig, K.R. and Larsen, S., 2008. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Women’s Health 8: 3.
'Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study ' () 8 BMC Women’s Health : 3.
-
Laue, C., Papazova, E., Liesegang, A., Pannenbeckers, A., Arendarski, P., Linnerth, B., Domig, K.J., Kneifel, W., Petricevic, L. and Schrezenmeir, J., 2018. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women – a double-blind, randomised, controlled clinical pilot trial. Beneficial Microbes 9: 35-50.
'Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women – a double-blind, randomised, controlled clinical pilot trial ' () 9 Beneficial Microbes : 35 -50.
-
Machado, D., Castro, J., Palmeira-de-Oliveira, A., Martinez-de-Oliveira, J. and Cerca, N., 2016. Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions. Frontiers in Microbiology 6: 1528.
'Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions ' () 6 Frontiers in Microbiology : 1528.
-
Martinez, R., Franceschini, S., Patta, M., Quintana, S.M., Gomes, B.C., De Martinis, E.C. and Reid, G., 2009. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Canadian Journal of Microbiology 55: 133-138.
'Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial ' () 55 Canadian Journal of Microbiology : 133 -138.
-
Mastromarino, P., Macchia, S., Meggiorini, L., Trinchieri, V., Mosca, L., Perluigi, M. and Midulla, C., 2009. Effectiveness of Lactobacillus containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clinical Microbiology and Infection 15: 67-74.
'Effectiveness of Lactobacillus containing vaginal tablets in the treatment of symptomatic bacterial vaginosis ' () 15 Clinical Microbiology and Infection : 67 -74.
-
Nugent, R.P., Krohn, M.A. and Hillier, S.L., 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology 29: 297-301.
'Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation ' () 29 Journal of Clinical Microbiology : 297 -301.
-
Otsuki, K. and Imai, N., 2017. Effects of lactoferrin in 6 patients with refractory bacterial vaginosis. Biochemistry and Cell Biology 95: 31-33.
'Effects of lactoferrin in 6 patients with refractory bacterial vaginosis ' () 95 Biochemistry and Cell Biology : 31 -33.
-
Otsuki, K., Tokunaka, M., Oba, T., Nakamura, M., Shirato, N. and Okai, T., 2014. Administration of oral and vaginal prebiotic lactoferrin for a woman with a refractory vaginitis recurring preterm delivery: appearance of Lactobacillus in vaginal flora followed by term delivery. Journal of Obstetreics and Gynaecology Research 40: 583-585.
'Administration of oral and vaginal prebiotic lactoferrin for a woman with a refractory vaginitis recurring preterm delivery: appearance of Lactobacillus in vaginal flora followed by term delivery ' () 40 Journal of Obstetreics and Gynaecology Research : 583 -585.
-
Pino, A., Giunta, G., Randazzo, C.L., Caruso, S., Caggia, C. and Cianci, A., 2017. Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microbial Ecology in Health and Disease 28: 1357417.
'Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial ' () 28 Microbial Ecology in Health and Disease : 1357417.
-
Pirotta, M., Fethers, K.A. and Bradshaw, C.S., 2009. Bacterial vaginosis – more questions than answers. Australian Family Physician 38: 394-397.
'Bacterial vaginosis – more questions than answers ' () 38 Australian Family Physician : 394 -397.
-
Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R. and Bruce, A.W., 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 35: 131-134.
'Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women ' () 35 FEMS Immunology and Medical Microbiology : 131 -134.
-
Russo, R., Edu, A. and De Seta, F., 2018. Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota. Archives of Gynecology and Obstetrics 298: 139-145.
'Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota ' () 298 Archives of Gynecology and Obstetrics : 139 -145.
-
Saunders, S., Bocking, A., Challis, J. and Reid, G., 2007. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids and Surfaces Biointerfaces 55: 138-142.
'Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms ' () 55 Colloids and Surfaces Biointerfaces : 138 -142.
-
Schwebke, J.R. and Desmond, R.A., 2011. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. American Journal of Obstetrics and Gynecology 204: 211.
'Tinidazole vs metronidazole for the treatment of bacterial vaginosis ' () 204 American Journal of Obstetrics and Gynecology : 211.
-
Senok, A.C., Verstraelen, H., Temmerman, M. and Botta, G., 2009. Probiotics for the treatment of bacterial vaginosis. Cochrane Database of Systematic Reviews 4: CD006289.
'Probiotics for the treatment of bacterial vaginosis ' () 4 Cochrane Database of Systematic Reviews : CD006289.
-
Sobel, J.D., 2006. Management of recurrent vulvovaginal candidiasis: unresolved issues. Current Infectious Disease Reports 8: 481-486.
'Management of recurrent vulvovaginal candidiasis: unresolved issues ' () 8 Current Infectious Disease Reports : 481 -486.
-
Unemo, M., Bradshaw, C.S., Hocking, J.S., De Vries, H.J.C., Francis, S.C., Mabey, D., Marrazzo, J.M., Sonder, G.J.B., Schwebke, J.R., Hoornenborg, E., Peeling, R.W., Philip, S.S., Low, N. and Fairley, C.K., 2017. Sexually transmitted infections: challenges ahead. Lancet Infectious Disease 17: e235-e279.
'Sexually transmitted infections: challenges ahead ' () 17 Lancet Infectious Disease : e235 -e279.
-
Verstraelen, H., Verhelst, R., Claeys, G., Temmerman, M. and Vaneechoutte, M., 2004. Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. American Journal of Obstetrics and Gynecology 191: 1130-1132.
'Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis ' () 191 American Journal of Obstetrics and Gynecology : 1130 -1132.
-
Vujic, G., Jajac Knez, A., Despot Stefanovic, V. and Kuzmic Vrbanovic, V., 2013. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blinded, randomized, placebo-controlled study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 168: 75e9.
'Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blinded, randomized, placebo-controlled study ' () 168 European Journal of Obstetrics, Gynecology, and Reproductive Biology : 75e9.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 5046 | 3573 | 192 |
| Full Text Views | 95 | 70 | 11 |
| PDF Views & Downloads | 188 | 130 | 16 |
Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial
In: Beneficial MicrobesSearch for other papers by R. Russo in
Current site
Google Scholar
PubMed
Search for other papers by E. Karadja in
Current site
Google Scholar
PubMed
Search for other papers by F. De Seta in
Current site
Google Scholar
PubMed
Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women. It is characterised by abnormal vaginal microbiota with a depletion of lactobacilli and predominance of anaerobic microorganisms, mainly Gardnerella vaginalis and Atopobium vaginae. Although antibiotics represent an effective therapeutic option in the short-term, recurrent infections still remain a serious problem. Nowadays, evidence exists about the efficacy of probiotics for the management of BV. The aim of the current double blind, randomised clinical trial was to assess the efficacy of a probiotic mixture, including Lactobacillus acidophilus GLA-14 and Lactobacillus rhamnosus HN001, in combination with bovine lactoferrin, as adjuvant therapy to metronidazole in women with recurrent BV. In particular, normalisation of Nugent score, remission of symptoms and recurrences during a six-months follow-up were assessed. 48 adult women received metronidazole (500 mg twice daily) for 7 days and randomly assigned to take simultaneously either probiotics plus lactoferrin or placebo (2 capsules/day for 5 days followed by 1 capsule/day for 10 consecutive days; induction phase). The verum or placebo administration (1 capsule/day for 10 consecutive days) was repeated each month (maintenance phase) during the six months of follow-up starting the first day of menstrual cycle since the menstrual blood increases the vaginal pH and contributes to increase the risk of recurrences. The results showed that symptoms (vaginal discharge and itching), Nugent score and recurrence rate were significantly improved by probiotics mixture in association with lactoferrin. This alternative approach may represent a safe and effective remedy for the restoration of healthy vaginal microbiota in preventing recurrent BV.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 5046 | 3573 | 192 |
| Full Text Views | 95 | 70 | 11 |
| PDF Views & Downloads | 188 | 130 | 16 |
